Iron Overload And Its Complications In Aceruloplasminemia
Published on: November 19, 2024
Iron Overload And Its Complications In Aceruloplasminemia
Article author photo

Brianna Marment-Payne

MSci Neuroscience - <a href="https://www.southampton.ac.uk/" rel="nofollow">University of Southampton</a>

Article reviewer photo

Ananthajith Rajesh

BSc Hons Biomedical Sciences, University of Edinburgh

Overview 

Aceruloplasminemia is a rare condition that causes a buildup of iron in cells across the body, with the main affected organs being the brain, the pancreas, and the eyes. The unique build-up of iron in the brain distinguishes aceruloplasminemia from other iron overload disorders.1 Despite it being a genetic condition, the age of onset ranges from infancy to late adulthood and varies in the rate of progression and symptom presentation.2

This article delves into the effect of iron overload in aceruloplasminemia and highlights the complications that may be experienced by those with the genetic disorder. 

What is aceruloplasminemia

Many disorders have long and complicated names. Whilst this can seem daunting, this naming system is used to help people read the word and partially understand the basics of the disorder. At a glance, aceruloplasminemia means ‘little to no ceruloplasmin in the plasma/blood’. Here is a word breakdown of aceruloplasminemia:

Part of wordDefinition
A-Meaning no, without or less 
-ceruloplasmin-A protein that carries copper and helps to break down iron
-emiaRelating to the blood

Iron overload in aceruloplasminemia 

The role of iron

Iron is a highly important mineral used in many biological processes. Eating foods with a good source of iron, like meat, eggs and leafy greens is important, as we do not naturally produce iron.3 The two most common forms of iron that we absorb from our diet are ferrous iron (Fe2+) and ferric iron (Fe3+).

One of the most important functions of iron in the body is to help make a protein called haemoglobin. This is a molecule found in red blood cells that binds to oxygen to transport it around the body via the bloodstream.4 Without haemoglobin, our organs wouldn’t receive enough oxygen, leaving us feeling tired and weak.

When we eat iron-rich foods, the natural pH of our bodies causes it to be converted into the Fe3+ form. However, to be absorbed by the enterocyte cells lining the small intestine, it must be changed into Fe2+.5

What is ceruloplasmin? 

Once inside these enterocytes, Fe2+ can be converted back to Fe3+ for storage, or exported out of the other side of the cells into the bloodstream. To be transported around in the blood, the iron needs to be in the correct shape to attach to the transporting molecule, known as transferrin.6 This means converting Fe2+ back into Fe3+

In healthy individuals, one of the proteins that aids this process is called ceruloplasmin. It sits on the outside of the enterocyte to allow for the movement of iron from cells into the bloodstream.7 Ceruloplasmin is mainly made in the liver, but small amounts are also made by cells in the retina and pancreas, as well as immune cells, like macrophages in the body, and astrocytes in the brain.8, 9

Ceruloplasmin has an additional protective effect.10 The Fe2+ form of iron can be quite toxic as it releases free radicals. These are highly reactive particles that want to steal electrons from DNA and other molecules, which in turn destabilise otherwise healthy cells.11

Ceruloplasmin’s role in converting Fe2+ into the Fe3+ form not only helps its movement into the plasma and bloodstream but also acts as an antioxidant by pairing up with free radicals to stop them from causing damage.10

How the lack of ceruloplasmin leads to iron accumulation

Dysfunction or complete lack of ceruloplasmin in the body reduces the amount of iron that enters the bloodstream from the enterocytes. However, dietary iron is still absorbed into the enterocytes that line the small intestine. Since absorption remains at the same level, but the export is significantly reduced, iron begins to build up inside the enterocytes, leading to iron overload.2

Complications of aceruloplasminemia

Blood-related

Iron is one of the main components of red blood cells. As previously mentioned, its role in the production of haemoglobin is central to the ability of red blood cells to carry oxygen around the body.4 The lack of ceruloplasmin in those with aceruloplasminemia means iron in the Fe3+ form cannot be sent to the bone marrow for red blood cell production. The red blood cells that are made tend to be a lot smaller as they are missing the haemoglobin component.5 As a result, 80% of people with aceruloplasminemia have iron-restricted microcytic anaemia, a condition resulting in reduced oxygen delivery to the tissues of the body.2 Symptoms of this type of anaemia are general weakness, dizziness and an increased heart rate. 

Neurological

One of the main complications seen in 68% of people with aceruloplasminemia is related to the buildup of iron in the brain, causing neurological issues.2 For this reason, aceruloplasminemia is primarily described as a neurodegenerative disorder. Degeneration of brain tissue is largely irreversible, therefore recognising aceruloplasminemia in its early stages is vital to prevent further brain damage. 

The neurological complications seen in aceruloplasminemia will vary depending on where in the brain the iron accumulation occurs.12 The table below highlights the regions of the brain that have been linked to iron buildup in aceruloplasminemia, and the associated symptoms. 

Region/cell type Role Associated symptoms caused by iron buildup 
Basal ganglia (a group of structures in the centre of the brain)Responsible for voluntary movement, habit formation and some decision-making.13Tremors Facial and neck muscle dystoniaSlurred speech (dysarthria)14
Cerebral cortex (the outer layer of the brain, divided into 4 lobes)Responsible for thinking, problem-solving, memory and emotions15DementiaConfusion1
Cerebellum (the base of the brain, near the spinal cord)Responsible for motor skills, like balance, posture and coordination 16Lack of coordination (ataxia)Uncontrolled movements (Dystonia)9
Astrocytes (immune cells in the brain)Responsible for general maintenance in the brain and provides structural support and protection for neurons17Loss of neuronal protection can manifest as cognitive decline as seen in dementia17 

Pancreatic 

The presence of diabetes is also seen as an early indicator, with reports of 70% of individuals with aceruloplasminemia showing signs of diabetes.18

In healthy individuals, the cells in the pancreas respond to the intake of sugar by producing a hormone called insulin. Insulin plays a vital role in encouraging the uptake of sugar into cells, so it can be used for energy. In diabetes, the pancreatic cells become damaged and are unable to release insulin which results in increased blood sugar.2

It is the gradual build-up of iron in the pancreas that drives the dysfunction seen in aceruloplasminemia. As a result, the pancreatic cells are damaged by the free radicals and unable to release insulin.19

Visual

Another main complication seen in aceruloplasminemia is eye disease. Around 76% of people with this disorder experience retinal degeneration, which is progressive damage to the back of the eye.2 This damage can be caused directly by an iron buildup in the retinal cells or as a result of diabetes induced by aceruloplasminemia.

The retina is located at the back of the eye and consists of a layer of cells that captures incoming light and converts it into signals that are processed in the brain, allowing us to see. The lack of ceruloplasmin in aceruloplasminemia means that Fe2+ can’t be converted into Fe3+, leaving free radicals free to damage the retinal cells, resulting in retinal degeneration.20

Eye disease is also something to look out for in diabetes. A large network of tiny blood vessels supplies the eyes with oxygen and nutrients. As people with diabetes are unable to produce insulin, they often experience high blood sugar. Over time, high volumes of sugar in the blood can damage the eye and cause the gradual loss of vision.21

Summary 

There is a main triad of complications seen in individuals with aceruloplasminemia, those being neurological problems, retinal degradation and diabetes. Although these symptoms are the most common, iron overload in aceruloplasminemia has damaging effects across all systems of the body. For this reason, it is important to watch out for the onset of these symptoms, particularly if there is a family history of aceruloplasminemia.

References

  1. Miyajima H, Takahashi Y, Kono S. Aceruloplasminemia, an inherited disorder of iron metabolism. Biometals. 2003 Mar;16(1):205–13. [cited 2024 Jul 22] Available from: https://pubmed.ncbi.nlm.nih.gov/12572680/
  2. Miyajima H, Hosoi Y. Aceruloplasminemia. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2024 Jul 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1493/
  3. Moustarah F, Daley SF. Dietary iron. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jul 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK540969/
  4. Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci [Internet]. 2014 Feb [cited 2024 Jul 24];19(2):164–74. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999603/
  5. Anderson ER, Shah YM. Iron homeostasis in the liver. Compr Physiol [Internet]. 2013 Jan [cited 2024 Jul 25];3(1):315–30. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936199/
  6. Armando Hasudungan. Iron physiology [Internet]. 2014 [cited 2024 Jul 25]. Available from: https://www.youtube.com/watch?v=ahCy97FVUpM
  7. Roeser HP, Lee GR, Nacht S, Cartwright GE. The role of ceruloplasmin in iron metabolism. J Clin Invest [Internet]. 1970 Dec [cited 2024 Jul 25];49(12):2408–17. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC322742/
  8. Lopez MJ, Royer A, Shah NJ. Biochemistry, ceruloplasmin. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jul 25]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554422/
  9. Wang B, Wang XP. Does ceruloplasmin defend against neurodegenerative diseases? Curr Neuropharmacol [Internet]. 2019 Jun [cited 2024 Jul 25];17(6):539–49. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712297/
  10. Patel BN, Dunn RJ, Jeong SY, Zhu Q, Julien JP, David S. Ceruloplasmin regulates iron levels in the cns and prevents free radical injury. J Neurosci [Internet]. 2002 Aug 1 [cited 2024 Jul 26];22(15):6578–86. Available from: https://www.jneurosci.org/content/22/15/6578
  11. Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev [Internet]. 2010 [cited 2024 Jul 26];4(8):118–26. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249911/
  12. Miyajima H. Aceruloplasminemia, an iron metabolic disorder. Neuropathology. 2003 Dec;23(4):345–50. [cited 2024 Jul 26] Available from: https://pubmed.ncbi.nlm.nih.gov/14719552/
  13. Lanciego JL, Luquin N, Obeso JA. Functional neuroanatomy of the basal ganglia. Cold Spring Harb Perspect Med [Internet]. 2012 Dec [cited 2024 Jul 26];2(12):a009621. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543080/
  14. Gregory A, Hayflick S. Neurodegeneration with brain iron accumulation disorders overview. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2024 Jul 26]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK121988/
  15. Jawabri KH, Sharma S. Physiology, cerebral cortex functions. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jul 26]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK538496/
  16. Jimsheleishvili S, Dididze M. Neuroanatomy, cerebellum. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jul 27]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK538167/
  17. Miyajima H. Astrocytes in aceruloplasminemia. In: Astrocyte - Physiology and Pathology [Internet]. IntechOpen; 2017 [cited 2024 Jul 25]. Available from: https://www.intechopen.com/chapters/57646
  18. Vroegindeweij LHP, van der Beek EH, Boon AJW, Hoogendoorn M, Kievit JA, Wilson JHP, et al. Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series. Diabet Med. 2015 Aug;32(8):993–1000. Available from: https://pubmed.ncbi.nlm.nih.gov/25661792/
  19. Marku A, Galli A, Marciani P, Dule N, Perego C, Castagna M. Iron metabolism in pancreatic beta-cell function and dysfunction. Cells. 2021 Oct 22;10(11):2841. [cited 2024 Jul 26] Available from: https://pubmed.ncbi.nlm.nih.gov/34831062/
  20. Wolkow N, Song Y, Wu TD, Qian J, Guerquin-Kern JL, Dunaief JL. Aceruloplasminemia: retinal histopathology and iron-mediated melanosome degradation. Arch Ophthalmol [Internet]. 2011 Nov [cited 2024 Jul 26];129(11):1466–74. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089978/
  21. Shukla UV, Tripathy K. Diabetic retinopathy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jul 26]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK560805/
Share

Brianna Marment-Payne

MSci Neuroscience - University of Southampton

I'm a neuroscience graduate with a strong interest in medical writing, always seeking new ways to grow and develop in both a personal and professional manner. My enthusiasm for science communication and innovative research has been recognised by the Royal Society of Biology, having been awarded with the Top Project Award for my research into the effect of psilocybin on neuroinflammation.

arrow-right